News in the Life Sciences Industry

HAMBURG, Germany, Sept. 30, 2019 /PRNewswire/ -- Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and Indivumed GmbH announced today that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment... Read more ››

LONDON, Sept. 29, 2019 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced results from PRIMA (ENGOT-OV26/GOG-3012), the Phase 3 randomised, double-blind, placebo-controlled study of Zejula (niraparib) as a maintenance therapy in women with first-line ovarian cancer following... Read more ››

LONDON, Sept. 28, 2019 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced results from PRIMA (ENGOT-OV26/GOG-3012), the Phase 3 randomised, double-blind, placebo-controlled study of Zejula (niraparib) as a maintenance therapy in women with first-line ovarian cancer following... Read more ››

COLOGNE, Germany, Sept. 27, 2019 /PRNewswire/ -- TUV Rheinland LGA Products GmbH is now a notified body for the EU Medical Device Regulation (MDR) 2017/745. The European Medical Device Regulation 2017/745 (MDR) came into effect on May 25, 2017, and will replace Directive 93/42/EEC (MDD) and Directive... Read more ››

MARTINSRIED, Germany and MUNICH, Sept. 26, 2019 /PRNewswire/ -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, announced today the presentation of two posters at the Fifth International Cancer lmmunotherapy Conference... Read more ››

SUZHOU, China, Sept. 26, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, announced today an expansion of its integrated clinical trials supply and distribution services network, in Suzhou, China, as well as a collaboration with Frontier Biotechnologies Inc.... Read more ››

Innovative technology helps address critical challenge of anastomotic leaks which can occur in up to 8.6% of colorectal surgeries(1),11% in oesophagectomies(2) and 4% in gastrectomies(3)

SAN ANTONIO, Sept. 24, 2019 /PRNewswire/ -- Bluegrass Vascular Technologies (Bluegrass Vascular), a private... Read more ››

BERLIN and BOSTON, Sept. 24, 2019 /PRNewswire/ -- Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases. The joint lab... Read more ››

SINGAPORE, Sept. 24, 2019 /PRNewswire/ -- Blue Sail Medical recently announced that the company made a purchase offer to acquire all shares of New Valve Technology (NVT) AG, Muri (Argau, Switzerland), and that the offer was accepted by the shareholders of NVT. The deal was publicly announced... Read more ››

ROME, Sept. 23, 2019 /PRNewswire/ -- Promising results from the preclinical study conducted by Menarini Ricerche on MEN1611, a potent and selective orally available phosphatidylinositol 3-kinase (PI3K) inhibitor currently in development for the treatment of breast cancer. The poster entitled... Read more ››

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer

- Osteoporosis is estimated to affect 200 million people worldwide(1) and results in a fracture every 3 seconds(2) yet a new survey reveals bone specialists in Europe think its impact is not fully recognised(3)

BOLOGNA, Italy, Sept. 19, 2019 /PRNewswire/ -- Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow* for liquid biopsy and formalin-fixed paraffin embedded (FFPE) tissue analysis, and provides a powerful... Read more ››

First-time positive results of EO(2) Oxygen Delivery System with frequent debridement

MARSA, Malta, Sept. 18, 2019 /PRNewswire/ -- "Love has no limit [...] and when you do what you love, magic is very real." * Legendary footballer Roberto Carlos spoke to children who had or had been through cancer about the importance of doing what you love and how this leads to where you want... Read more ››

ABBOTT PARK, Ill., Sept. 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP(TM) 15mm rotatable mechanical heart valve and the Amplatzer Piccolo(TM) Occluder have received CE Mark and are now available in... Read more ››